About mRNA

We are adapting our PODular approach to bring to market an end to end mRNA and DNA vaccine manufacturing platform using Touchlight’s dbDNA and Cytiva’s Single-use closed system FlexFactory mRNA, LNP to Vanrx fill finish technology within Ireland for broader PODular application across the EU